Tidemark’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-4
Closed -$337 628
2024
Q2
$337 Hold
4
﹤0.01% 594
2024
Q1
$292 Hold
4
﹤0.01% 673
2023
Q4
$286 Buy
+4
New +$286 ﹤0.01% 671